Table 2.
Cost-effectiveness results for pre-adolescent girls.*
| Kenya† | Mozambique† | Tanzania† | Uganda† | |
|---|---|---|---|---|
| I$/YLS | I$/YLS | I$/YLS | I$/YLS | |
| Adolescent vaccination followed by a single lifetime HPV DNA testing at age 35 (1-visit)‡ | ||||
| Cost per vaccinated girl: I$5 (I$0.55 per dose) | ||||
| Vaccine | 160 | 80 | CS | 20 |
| Screening with HPV, age 35 | § | § | § | § |
| Vaccine + screening with HPV, age 35 | 2090 | 1260 | 740 | 1000 |
| Cost per vaccinated girl: I$10 (I$2.00 per dose) | ||||
| Vaccine | 470 | 250 | 90 | 130 |
| Screening with HPV, age 35 | § | § | § | § |
| Vaccine + screening with HPV, age 35 | 2090 | 1260 | 740 | 1000 |
| Cost per vaccinated girl: I$25 (I$5.00 per dose) | ||||
| Screening with HPV, age 35 | 1400 | § | § | § |
| Vaccine | 1440 | 750 | 440 | 490 |
| Vaccine + screening with HPV, age 35 | 2090 | 1260 | 740 | 1000 |
| Cost per vaccinated girl: I$50 (I$12.25 per dose) | ||||
| Screening with HPV, age 35 | 1400 | 770 | 450 | 570 |
| Vaccine | § | § | § | § |
| Vaccine + screening with HPV, age 35 | 3580 | 1870 | 1260 | 1300 |
| Cost per vaccinated girl: I$200 (I$54.25 per dose) | ||||
| Screening with HPV, age 35 | 1400 | 770 | 450 | 570 |
| Vaccine | § | § | § | § |
| Vaccine + screening with HPV, age 35 | 15,000 | 7850 | 5610 | 5610 |
| Adolescent vaccination followed by a single lifetime HPV DNA testing at age 35 (2-visit)‡ | ||||
| Cost per vaccinated girl: I$5 (I$0.55 per dose) | ||||
| Vaccine | 160 | 80 | CS | 20 |
| Screening with HPV, age 35 | § | § | § | § |
| Vaccine + screening with HPV, age 35 | 2810 | 1690 | 1060 | 1370 |
| Cost per vaccinated girl: I$10 (I$2.00 per dose) | ||||
| Vaccine | 470 | 250 | 90 | 130 |
| Screening with HPV, age 35 | § | § | § | § |
| Vaccine + screening with HPV, age 35 | 2810 | 1690 | 1060 | 1370 |
| Cost per vaccinated girl: I$25 (I$5.00 per dose) | ||||
| Screening with HPV, age 35 | § | § | § | § |
| Vaccine | 1420 | 750 | 440 | 490 |
| Vaccine + screening with HPV, age 35 | 2810 | 1690 | 1060 | 1370 |
| Cost per vaccinated girl: I$50 (I$12.25 per dose) | ||||
| Screening with HPV, age 35 | 1860 | 1010 | 630 | 770 |
| Vaccine | § | § | § | 1240 |
| Vaccine + screening with HPV, age 35 | 3480 | 1830 | 1220 | 1370 |
| Cost per vaccinated girl: I$200 (I$54.25 per dose) | ||||
| Screening with HPV, age 35 | 1860 | 1010 | 630 | 770 |
| Vaccine | § | § | § | § |
| Vaccine + screening with HPV, age 35 | 14,570 | 7650 | 5420 | 5450 |
YLS = years of life saved; HPV = human papillomavirus DNA testing; CS = cost-saving. All currencies are reported in 2005 international dollars (I$).
Gross domestic product (GDP) per capita, 2005 I$ for each country is as follows: Kenya (I$1470); Mozambique (I$791); Tanzania (I$1167); Uganda (I$1077).28
Analyses assume either 1-visit HPV testing or 2-visit HPV testing. The results should be interpreted assuming that a country has already decided to utilize a 1-visit or 2-visit strategy. Analyses that rely on alternative assumptions are provided in the Appendix.
These strategies are either more costly and less effective, or have higher incremental cost-effectiveness ratios than more effective options, and are thus considered dominated.